EMEA-000035-PIP01-07-M05

Key facts

Invented name
Spiriva Respimat and associated names
Active substance
Tiotropium bromide (monohydrate)
Therapeutic area
Pneumology-allergology
Decision number
P/0105/2012
PIP number
EMEA-000035-PIP01-07-M05
Pharmaceutical form(s)
Solution for inhalation via the Respimat inhaler
Condition(s) / indication(s)
Treatment of cystic fibrosis
Route(s) of administration
Inhalation use
Contact for public enquiries
Boehringer Ingelheim International GmbH

Tel. +49 6132778271
E-mail: paediatrics@boehringer-ingelheim.com

 

Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
Compliance opinion date
21/08/2012
Compliance outcome
positive

Decision

How useful was this page?

Add your rating